Mary F. Kearney

Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy

Nancie M. Archin, Abigail Liberty, Angela D. M. Kashuba et al. · Nature · 2012 · 1.2K citations

Pharmacy, Pharmacokinetics, Pharmacology +12

Specific HIV integration sites are linked to clonal expansion and persistence of infected cells

Frank Maldarelli, Xiaolin Wu, Li Su et al. · Science · 2014 · 895 citations

Life Sciences, Infectious Diseases, Molecular Biology +15

Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome

Qin Yu, Renate König, Satish K. Pillai et al. · Nature Structural & Molecular Biology · 2004 · 596 citations

Life Sciences, Genetics, Molecular Biology +5

Multiple, Linked Human Immunodeficiency Virus Type 1 Drug Resistance Mutations in Treatment-Experienced Patients Are Missed by Standard Genotype Analysis

Sarah Palmer, Mary F. Kearney, Frank Maldarelli et al. · Journal of Clinical Microbiology · 2005 · 511 citations · Full text

Life Sciences, Pharmacology, Molecular Virology +15

Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy

Jason B. Dinoso, S. Y. Kim, Ann Wiegand et al. · Proceedings of the National Academy of Sciences · 2009 · 445 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +16